Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with... by Al-Batran, Salah-Eddin, Prof, Hofheinz, Ralf D, Prof, Pauligk, Claudia, PhD, Kopp, Hans-Georg, MD, Haag, Georg Martin, MD, Luley, Kim Barbara, MD, Meiler, Johannes, MD, Homann, Nils, Prof, Lorenzen, Sylvie, MD, Schmalenberg, Harald, MD, Probst, Stephan, MD, Koenigsmann, Michael, Prof, Egger, Matthias, MD, Prasnikar, Nicole, MD, Caca, Karel, Prof, Trojan, Jörg, Prof, Martens, Uwe M, Prof, Block, Andreas, MD, Fischbach, Wolfgang, Prof, Mahlberg, Rolf, MD, Clemens, Michael, Prof, Illerhaus, Gerald, Prof, Zirlik, Katja, MD, Behringer, Dirk M, Prof, Schmiegel, Wolff, Prof, Pohl, Michael, MD, Heike, Michael, Prof, Ronellenfitsch, Ulrich, MD, Schuler, Martin, Prof, Bechstein, Wolf O, Prof, Königsrainer, Alfred, Prof, Gaiser, Timo, Prof, Schirmacher, Peter, Prof, Hozaeel, Wael, MD, Reichart, Alexander, MD, Goetze, Thorsten O, MD, Sievert, Mark, MD, Jäger, Elke, Prof, Mönig, Stefan, Prof, Tannapfel, Andrea, Prof

Get full text

Efficacy of ramucirumab combination chemotherapy as second‐line treatment in patients with advanced adenocarcinoma of the stomach or gastroesophageal junction after exposure to che... by Masetti, Michael, Al‐Batran, Salah‐Eddin, Goetze, Thorsten O., Thuss‐Patience, Peter, Knorrenschild, Jorge Riera, Goekkurt, Eray, Folprecht, Gunnar, Ettrich, Thomas Jens, Lindig, Udo, Luley, Kim Barbara, Pink, Daniel, Dechow, Tobias, Sookthai, Disorn, Junge, Sabine, Loose, Maria, Pauligk, Claudia, Lorenzen, Sylvie

Get full text

Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after... by Lorenzen, Sylvie, Knorrenschild, Jorge Riera, Pauligk, Claudia, Hegewisch‐Becker, Susanna, Seraphin, Jörg, Thuss‐Patience, Peter, Kopp, Hans‐Georg, Dechow, Tobias, Vogel, Arndt, Luley, Kim Barbara, Pink, Daniel, Stahl, Michael, Kullmann, Frank, Hebart, Holger, Siveke, Jens, Egger, Matthias, Homann, Nils, Probst, Stephan, Goetze, Thorsten Oliver, Al‐Batran, Salah‐Eddin

Get full text

Favorable prognostic impact of RAS mutation status in multiple myeloma treated with high-dose melphalan and autologous stem cell support in the era of novel agents: a single center... by Gebauer, Niklas, Biersack, Harald, Czerwinska, Ann-Cathrin, Schemme, Janina, Hardel, Tim Tristan, Bernard, Veronica, Rades, Dirk, Lehnert, Hendrik, Luley, Kim Barbara, Thorns, Christoph

Get full text

Single nucleotide polymorphisms in TP53 but not KRAS or MDM2 are predictive of clinical outcome in multiple myeloma treated with high-dose melphalan and autologous stem cell suppor... by Gebauer, Niklas, Biersack, Harald, Czerwinska, Ann-Cathrin, Schemme, Janina, Hardel, Tim Tristan, Bernard, Veronica, Rades, Dirk, Lehnert, Hendrik, Luley, Kim Barbara, Thorns, Christoph

Get full text

Community-driven development of a modified progression-free survival ratio for precision oncology by Mock, Andreas, Heilig, Christoph E, Kreutzfeldt, Simon, Huebschmann, Daniel, Heining, Christoph, Schröck, Evelin, Brors, Benedikt, Stenzinger, Albrecht, Jäger, Dirk, Schlenk, Richard, Glimm, Hanno, Fröhling, Stefan, Horak, Peter

Get full text